3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Recurrence
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Nasopharyngeal Carcinoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Graft vs Host Disease
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer With Liver Metastases
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
6
pembrolizumab
5
Carboplatin
5
durvalumab
4
Paclitaxel
4
Cetuximab
4
cemiplimab
3
Radiation
3
Platinum
3
Pemetrexed
3
Nivolumab
3
Docetaxel
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy
2
Immunoglobulin G
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
trifluridine tipiracil drug combination
1
repotrectinib
1
regorafenib
1
poly ICLC
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Drug Therapy
×
30 days
×
Clear all
No trials found.